丹参
传统医学
多酚
抗氧化剂
药理学
消炎药
发病机制
细胞粘附分子
医学
异黄酮素
脂蛋白
毛花素
炎症
ICAM-1
VCAM-1
化学
生物化学
中医药
胆固醇
免疫学
病理
染料木素
内科学
芒柄花素
替代医学
大豆黄酮
作者
Ming‐Shi Shiao,Jing‐Jing Chiu,Wei‐Ping Jen,Bao‐Wen Chang,Jane Wang,Ye‐Jer Wu,Yuh‐Lien Chen
出处
期刊:Biofactors
[Wiley]
日期:2008-01-01
卷期号:34 (2): 147-157
被引量:35
标识
DOI:10.1002/biof.5520340206
摘要
Abstract Many recent studies have suggested that low‐density lipoprotein (LDL) oxidation, endothelial dysfunction, and inflammation are involved in the pathogenesis of atherosclerosis. Herbal regimens in the treatment of blood stasis, a counterpart of atherosclerosis, commonly use medicinal plants of leguminosae and labiatae. We have developed disease‐oriented screening methods to search for bioactive components, particularly isoflavones in leguminosae and polyphenols in labiatae from Chinese herbal medicines. Many bioactive components and active fractions capable of inhibiting a. Cu(II)‐induced LDL oxidation, b. oxidized LDL‐induced endothelial damage, c. uptake of oxidized LDL by macrophages (J774A.1), and d. expression of cell adhesion molecules (CAMs) have been identified. A polyphenol, namely salvianolic acid B from Salvia miltiorrhiza was identified to be a potent antioxidant, endothelial‐protecting agent, and an inhibitor to suppress the expression of ICAM and VCAM. This review also briefly describes the strategy for developing herbal medicines as anti‐atherosclerotic agents.
科研通智能强力驱动
Strongly Powered by AbleSci AI